# REGENERATIVE RESEARCH FOUNDATION: Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | REGENERATIVE RESEARCH FOUNDATION |
| Location | Albany, NY |
| Project | Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration |
| Project number | 2UH3EY031810-06 |
| Mechanism | UH3 |
| Institute | National Eye Institute |
| Award | $1,063,571 |
| Awarded | 2026-09-11 |
| Project period | 2020-09-30 to 2028-09-29 |
| UEI | LLCNGSLHHLJ5 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11436542). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.